Clonazepam for Anxiety and Muscle Spasm Management After an Accident

James Wong — Founder & Pharmacist, LienScripts | September 27, 2024 | 7 min read

Clonazepam (Klonopin) is a long-acting benzodiazepine prescribed for anxiety disorders and sometimes for spasticity and spasm in personal injury cases. Understanding when it's appropriate, its legal documentation context, and how to navigate its use in PI cases helps attorneys and patients.

[!KEY] Clonazepam (Klonopin) is a long-acting Schedule IV benzodiazepine reserved for documented panic disorder, severe PTSD anxiety, or spasticity in PI cases; its prescribing is clinically defensible when the treating physician has documented the specific indication and the records show appropriate monitoring — but it requires stronger documentation than non-scheduled alternatives precisely because defense counsel scrutinizes benzodiazepine prescriptions.

What Is Clonazepam?

Clonazepam (brand name Klonopin) is a Schedule IV benzodiazepine with longer duration of action than agents like lorazepam or diazepam. It is FDA-approved for the treatment of panic disorder, certain seizure disorders, and has off-label use for anxiety disorders and spasticity.

In personal injury cases, clonazepam may be prescribed by a psychiatrist or treating physician for:

• Panic disorder or significant anxiety following the traumatic event — particularly in patients who have developed panic attacks or severe situational anxiety after an accident
• PTSD with significant anxiety or hyperarousal — where a longer-acting benzodiazepine may bridge the period before SSRI therapy becomes effective
• Spasticity or spasm in cases involving spinal cord injury or significant neurological involvement — clonazepam has muscle-relaxant properties that make it useful in this context
• Sleep maintenance insomnia with significant anxiety component — the long half-life makes it useful for sleep that is repeatedly disrupted by anxiety rather than initial sleep onset issues

Benzodiazepines in the PI Legal Context

Benzodiazepine prescribing in PI cases requires clinical and legal awareness. The clinical appropriateness of a benzodiazepine prescription in a PI case is defensible when:

• The prescribing physician has documented the specific indication (panic disorder, severe PTSD anxiety, spasticity)
• The prescription follows appropriate clinical guidelines (benzodiazepines are generally recommended for short-term or adjunctive use, not long-term monotherapy for anxiety)
• The patient's clinical records show monitoring of the prescription and reassessment of the indication over time
• The prescribing is by a psychiatrist or physician with documented training in anxiety disorder management

Defense counsel in PI cases often scrutinizes benzodiazepine prescriptions. The appropriate response is clinical documentation: the prescribing physician made a medically appropriate decision based on the patient's clinical presentation, and the prescription is consistent with recognized treatment guidelines for the documented condition.

Non-Benzodiazepine Alternatives

For many PI patients with post-accident anxiety, non-benzodiazepine alternatives are equally or more appropriate:

• Hydroxyzine for acute anxiety management without schedule concerns or dependence risk
• SSRIs (sertraline, escitalopram) as first-line pharmacotherapy for PTSD and anxiety disorders, with effects developing over 4-6 weeks
• Buspirone for generalized anxiety as a non-scheduled, non-habit-forming alternative
• Propranolol for situational anxiety (driving phobia, specific triggers) without CNS sedation

Physicians who choose clonazepam over these alternatives typically have a specific clinical reason — the severity of the patient's acute anxiety, a previous documented response to benzodiazepines, or the presence of a seizure disorder alongside the anxiety that requires benzodiazepine coverage.

[!KEY] When a treating psychiatrist chooses clonazepam over hydroxyzine or an SSRI, the chart note documenting that choice — specifying severity, prior medication failures, or the neurological basis for benzodiazepine selection — is the clinical evidence that distinguishes appropriate psychiatric management from the drug-seeking narrative defense counsel will attempt to construct.

Clonazepam and Opioid Co-Prescribing

[!TIP] Attorneys managing cases with concurrent opioid and clonazepam prescriptions should secure strong clinical documentation from both prescribing physicians explaining the independent indications and their awareness of the FDA black box warning — this proactive documentation is the best defense against challenges to the combination.

The FDA black box warning for concurrent opioid and benzodiazepine use is directly relevant to PI cases where patients may be on opioid analgesics for pain and clonazepam for anxiety. This combination carries elevated risk of respiratory depression and is a clinically sensitive area.

When both agents are prescribed in a PI case, the LienScripts pharmacist review will flag the combination. The pharmacist may contact the prescribing physicians to confirm clinical oversight of the combined regimen.

Attorneys managing cases with both opioid and benzodiazepine prescriptions should be aware that defense counsel may challenge the combination as inappropriate prescribing. Strong clinical documentation from both prescribers is essential.

Coverage Under a Pharmacy Lien

Clonazepam prescribed for documented injury-related anxiety, panic disorder, or spasticity in a PI case is covered under a LienScripts pharmacy lien, reviewed case by case. As a Schedule IV controlled substance, dispensing requires appropriate prescription documentation.

[!KEY] The LienScripts pharmacist review of a clonazepam prescription creates a documented clinical checkpoint — when a pharmacist confirms appropriate indication, screens for opioid co-prescribing risk, and approves dispensing, that review becomes part of the case record showing the entire medication regimen was professionally monitored, not passively dispensed.

The LienScripts pharmacist review will evaluate:

• The documented indication for benzodiazepine prescribing
• Any concurrent CNS depressant medications (opioids, muscle relaxants, other sedatives)
• The overall medication regimen for interaction risks

For PI patients who have been prescribed clonazepam by their treating psychiatrist or physician and are having difficulty maintaining coverage, pharmacy lien access ensures continuity without financial interruption. For more information, visit for patients.

Related Resources

• Pharmacy Services for Personal Injury Clients: How It Works
• What Are Medication Liens?